amyotrophic lateral sclerosis (3)
antineoplastic combined chemotherapy protocols (3)
breast neoplasms (3)
glial cell line-derived neurotrophic factor (3)
health care costs (3)
induced pluripotent stem cells (3)
insurance, health (3)
insurance, pharmaceutical services (3)
chronic disease (2)
continuous positive airway pressure (2)
disease management (2)
dopaminergic neurons (2)
drug costs (2)
economics, pharmaceutical (2)
lymphoma, non-hodgkin (2)
neural stem cells (2)
neutropenia (2)
quality of life (2)
sleep apnea syndromes (2)
03 medical and health sciences (1)
0301 basic medicine (1)
030104 developmental biology (1)
0302 clinical medicine (1)
030217 neurology & neurosurgery (1)
adverse effect (1)
animal diseases (1)
antibodies, monoclonal (1)
arthritis, rheumatoid (1)
astrocytes (1)
biological products (1)
biology (1)
biology.protein (1)
brain neoplasms (1)
business (1)
business.industry (1)
calcium (1)
central nervous system (1)
chemotherapy, adjuvant (1)
colony-stimulating factors (1)
cyclophosphamide (1)
databases, factual (1)
dependovirus (1)
doxorubicin (1)
drug utilization (1)
drugs, prescription (1)
eczema (1)
education, medical, continuing (1)
epidermal growth factor (1)
fever (1)
gene expression regulation, developmental (1)